Stock Performance Spotlight: GeneDx Holdings Corp (WGS) Ends the Day at 36.84, Down by -5.71

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, GeneDx Holdings Corp’s stock clocked out at $36.84, down -5.71% from its previous closing price of $39.07. In other words, the price has decreased by -$5.71 from its previous closing price. On the day, 0.71 million shares were traded. WGS stock price reached its highest trading level at $39.3367 during the session, while it also had its lowest trading level at $35.91.

Ratios:

To gain a deeper understanding of WGS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.22 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.58.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Equal Weight rating and assigned the stock a target price of $34.

On July 10, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $43.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 17 ’24 when OPKO HEALTH, INC. bought 13,404 shares for $40.88 per share.

Stueland Katherine sold 10,501 shares of WGS for $394,733 on Sep 16 ’24. The Chief Executive Officer now owns 103,706 shares after completing the transaction at $37.59 per share. On Sep 16 ’24, another insider, Feeley Kevin, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 2,635 shares for $37.59 each. As a result, the insider received 99,050 and left with 44,472 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WGS now has a Market Capitalization of 992318592 and an Enterprise Value of 1002419456. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.07 while its Price-to-Book (P/B) ratio in mrq is 5.11. Its current Enterprise Value per Revenue stands at 4.114 whereas that against EBITDA is -15.226.

Stock Price History:

Over the past 52 weeks, WGS has reached a high of $43.32, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 8.68%, while the 200-Day Moving Average is calculated to be 104.91%.

Shares Statistics:

It appears that WGS traded 443.32K shares on average per day over the past three months and 470520 shares per day over the past ten days. A total of 25.98M shares are outstanding, with a floating share count of 19.13M. Insiders hold about 28.96% of the company’s shares, while institutions hold 58.62% stake in the company. Shares short for WGS as of 1724976000 were 2188283 with a Short Ratio of 5.00, compared to 1722384000 on 1900943. Therefore, it implies a Short% of Shares Outstanding of 2188283 and a Short% of Float of 22.11.

Most Popular